SCHEMBL7668967

SCHEMBL7668967

CN1CCCC1COc1cncc(Br)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 11/20 1.00
CHRNA4 P43681 7/20 1.00
CHRNA3 P32297 6/20 0.74
CHRNB4 P30926 5/20 0.74
CHRNB1 P11230 4/20 0.74
CHRNB3 Q05901 4/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2439794 1.00 CHRNB2 (1.00) CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1
SCHEMBL6587460 1.00 CHRNB2 (1.00) CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1
Hydrochloric Acid SCHEMBL7460621 0.99 CHRNB2 (0.97) CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1
Hydrochloric Acid SCHEMBL7411062 0.99 CHRNB2 (0.97) CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1
SCHEMBL13308148 0.92 CHRNB2 (0.85) CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1
SCHEMBL2439661 0.92 CHRNB2 (0.85) CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1
Hydrochloric Acid SCHEMBL7459220 0.90 CHRNB2 (0.82) CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1
SCHEMBL8440528 0.85 CHRNB2 (0.76) CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1
SCHEMBL905212 0.85 CHRNB2 (1.00) CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1
Hydrochloric Acid SCHEMBL7450140 0.84 CHRNB2 (0.74) CHRNB2CHRNA4CHRNA3CHRNB4CHRNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6437138-B1 5-BROMO-6-CHLORO-3-(2-(S)-AZETIDINYL OR PYRROLIDINYL-METHOXY) PYRIDINE INTERMEDIATES FOR THE 5-SUBSTITUTED COMPOUNDS WHICH ARE POTENT LIGANDS AT NEURONAL NICOTINIC CHOLINERGIC CHANNEL RECEPTORS, NEUROTRANSMITTER CONTROLLING AGENTS ABBOTT LABORATORIES 2002-08-20 US disclosed